CA1101847A - Process for the concentration of a placenta-specific glycoprotein - Google Patents
Process for the concentration of a placenta-specific glycoproteinInfo
- Publication number
- CA1101847A CA1101847A CA276,303A CA276303A CA1101847A CA 1101847 A CA1101847 A CA 1101847A CA 276303 A CA276303 A CA 276303A CA 1101847 A CA1101847 A CA 1101847A
- Authority
- CA
- Canada
- Prior art keywords
- solution
- carrier
- protein
- value
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 230000008569 process Effects 0.000 title claims abstract description 29
- 210000002826 placenta Anatomy 0.000 title claims abstract description 8
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 239000000243 solution Substances 0.000 claims abstract description 31
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- 239000000126 substance Substances 0.000 claims abstract description 13
- 239000012736 aqueous medium Substances 0.000 claims abstract description 4
- 239000007791 liquid phase Substances 0.000 claims abstract description 4
- 239000012460 protein solution Substances 0.000 claims description 4
- 229920000936 Agarose Polymers 0.000 claims description 3
- 239000000032 diagnostic agent Substances 0.000 claims description 3
- 229940039227 diagnostic agent Drugs 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 abstract description 2
- 238000003795 desorption Methods 0.000 abstract description 2
- 239000003463 adsorbent Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 11
- 238000001179 sorption measurement Methods 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 230000003169 placental effect Effects 0.000 description 9
- 239000007853 buffer solution Substances 0.000 description 8
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 238000005194 fractionation Methods 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000012266 salt solution Substances 0.000 description 4
- 108010017384 Blood Proteins Proteins 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 3
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 3
- 102000008217 Pregnancy Proteins Human genes 0.000 description 3
- 239000006286 aqueous extract Substances 0.000 description 3
- 238000010923 batch production Methods 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NYEPHMYJRNWPLA-UHFFFAOYSA-N (6-amino-2-ethoxyacridin-9-yl)azanium;2-hydroxypropanoate;hydrate Chemical compound O.CC(O)C([O-])=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3[NH+]=C21 NYEPHMYJRNWPLA-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 101710158668 Placental protein Proteins 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002808 molecular sieve Substances 0.000 description 2
- 229940092253 ovalbumin Drugs 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- VRQURTHVUQBIMS-UHFFFAOYSA-N 2-acridin-1-yloxyethane-1,1-diamine;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C1=CC=C2C=C3C(OCC(N)N)=CC=CC3=NC2=C1 VRQURTHVUQBIMS-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 229910020939 NaC104 Inorganic materials 0.000 description 1
- 108010035746 Pregnancy Proteins Proteins 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- -1 alkali metal salts Chemical class 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- YYXLGGIKSIZHSF-UHFFFAOYSA-N ethene;furan-2,5-dione Chemical compound C=C.O=C1OC(=O)C=C1 YYXLGGIKSIZHSF-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 108010074605 gamma-Globulins Proteins 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- UYCAUPASBSROMS-UHFFFAOYSA-M sodium;2,2,2-trifluoroacetate Chemical compound [Na+].[O-]C(=O)C(F)(F)F UYCAUPASBSROMS-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 208000029387 trophoblastic neoplasm Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Pregnancy & Childbirth (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEP2616984.6 | 1976-04-17 | ||
| DE2616984A DE2616984C3 (de) | 1976-04-17 | 1976-04-17 | Verfahren zur Isolierung und Reinigung eines plazentenspezifischen Glycoproteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1101847A true CA1101847A (en) | 1981-05-26 |
Family
ID=5975638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA276,303A Expired CA1101847A (en) | 1976-04-17 | 1977-04-15 | Process for the concentration of a placenta-specific glycoprotein |
Country Status (20)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2640387C3 (de) * | 1976-09-08 | 1981-01-22 | Behringwerke Ag, 3550 Marburg | Gewebespezifisches Protein und Verfahren zu dessen Herstellung |
| DE2720704C2 (de) * | 1977-05-07 | 1986-09-25 | Behringwerke Ag, 3550 Marburg | Neues Glycoprotein, Verfahren zu seiner Herstellung und seine Verwendung |
| DE2745680A1 (de) * | 1977-10-11 | 1979-04-12 | Behringwerke Ag | Kontrazeptives mittel |
| EP0029893B1 (de) * | 1979-11-02 | 1987-05-20 | Karl Prof. Dr. Theurer | Verfahren zur Anreicherung tumorhemmender Wirkfaktoren |
| DE3013724A1 (de) | 1980-04-10 | 1981-10-15 | Behringwerke Ag, 3550 Marburg | Neues protein pp (pfeil abwaerts)9(pfeil abwaerts), verfahren zu seiner anreicherung und gewinnung sowieseine verwendung |
| DE3334405A1 (de) * | 1983-09-23 | 1985-04-04 | Behringwerke Ag, 3550 Marburg | Membranassoziierte proteine (mp(pfeil abwaerts)2(pfeil abwaerts)), verfahren zu ihrer gewinnung sowie ihre verwendung |
| NZ212523A (en) * | 1985-06-24 | 1989-01-06 | Univ Massey | Mobile phase for purification of proteins by high performance liquid chromatography |
| US20030220233A1 (en) | 1994-01-24 | 2003-11-27 | Neorx Corporation | Radiolabeled annexins |
| US5968477A (en) | 1994-01-24 | 1999-10-19 | Neorx Corporation | Radiolabeled annexin conjugates with hexose and a chelator |
| CA2190727C (en) * | 1994-05-19 | 2006-07-18 | Sudhakar Kasina | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
| US6005083A (en) | 1997-03-28 | 1999-12-21 | Neorx Corporation | Bridged aromatic substituted amine ligands with donor atoms |
-
1976
- 1976-04-17 DE DE2616984A patent/DE2616984C3/de not_active Expired
-
1977
- 1977-04-12 NL NL7703963A patent/NL7703963A/xx not_active Application Discontinuation
- 1977-04-12 ES ES457714A patent/ES457714A1/es not_active Expired
- 1977-04-14 CH CH465377A patent/CH630643A5/de not_active IP Right Cessation
- 1977-04-14 FI FI771186A patent/FI60875C/fi not_active IP Right Cessation
- 1977-04-15 SE SE7704359A patent/SE7704359L/ not_active Application Discontinuation
- 1977-04-15 NO NO771316A patent/NO146747C/no unknown
- 1977-04-15 AT AT266377A patent/AT362057B/de not_active IP Right Cessation
- 1977-04-15 GB GB15778/77A patent/GB1555197A/en not_active Expired
- 1977-04-15 NZ NZ183878A patent/NZ183878A/xx unknown
- 1977-04-15 IL IL51883A patent/IL51883A/xx unknown
- 1977-04-15 DK DK168577A patent/DK168577A/da not_active IP Right Cessation
- 1977-04-15 IT IT7722530A patent/IT1075832B/it active
- 1977-04-15 IE IE787/77A patent/IE44824B1/en unknown
- 1977-04-15 FR FR7711474A patent/FR2348222A1/fr active Granted
- 1977-04-15 AU AU24319/77A patent/AU517434B2/en not_active Expired
- 1977-04-15 LU LU77143A patent/LU77143A1/xx unknown
- 1977-04-15 CA CA276,303A patent/CA1101847A/en not_active Expired
- 1977-04-16 JP JP4316077A patent/JPS52154509A/ja active Pending
- 1977-04-18 BE BE176814A patent/BE853711A/xx unknown
- 1977-09-28 ES ES462699A patent/ES462699A1/es not_active Expired
-
1981
- 1981-12-15 CH CH800281A patent/CH632091A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI60875C (fi) | 1982-04-13 |
| JPS52154509A (en) | 1977-12-22 |
| CH630643A5 (en) | 1982-06-30 |
| DK168577A (da) | 1977-10-18 |
| FI60875B (fi) | 1981-12-31 |
| LU77143A1 (enrdf_load_html_response) | 1977-11-14 |
| NL7703963A (nl) | 1977-10-19 |
| ES462699A1 (es) | 1978-07-01 |
| IL51883A (en) | 1980-02-29 |
| FR2348222A1 (fr) | 1977-11-10 |
| IE44824B1 (en) | 1982-04-07 |
| NO146747C (no) | 1982-12-01 |
| SE7704359L (sv) | 1977-10-18 |
| NO146747B (no) | 1982-08-23 |
| IL51883A0 (en) | 1977-06-30 |
| BE853711A (fr) | 1977-10-18 |
| ATA266377A (de) | 1980-09-15 |
| IT1075832B (it) | 1985-04-22 |
| FR2348222B1 (enrdf_load_html_response) | 1980-02-08 |
| NZ183878A (en) | 1980-04-28 |
| NO771316L (no) | 1977-10-18 |
| GB1555197A (en) | 1979-11-07 |
| DE2616984C3 (de) | 1981-10-29 |
| DE2616984A1 (de) | 1977-10-20 |
| IE44824L (en) | 1977-10-17 |
| ES457714A1 (es) | 1978-02-16 |
| CH632091A5 (en) | 1982-09-15 |
| AT362057B (de) | 1981-04-27 |
| AU517434B2 (en) | 1981-07-30 |
| AU2431977A (en) | 1978-10-19 |
| DE2616984B2 (de) | 1981-01-29 |
| FI771186A7 (enrdf_load_html_response) | 1977-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4948874A (en) | Purified protein G from streptococcal bacteria | |
| SU1455999A3 (ru) | Способ получени дигиталис-антител | |
| CA1101847A (en) | Process for the concentration of a placenta-specific glycoprotein | |
| Fowler et al. | Analytical study of microsomes and isolated subcellular membranes from rat liver. V. Immunological localization of cytochrome b5 by electron microscopy: methodology and application to various subcellular fractions. | |
| SU1523046A3 (ru) | Способ очистки человеческого @ -интерферона | |
| US4191533A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
| US4312727A (en) | Glyoxal agarose and zonal immobilization of proteins therewith | |
| US4468345A (en) | Protein (PP17), a process for concentrating and isolating it and its use | |
| US4746731A (en) | Isolated tissue protein PP18 | |
| US4275196A (en) | Glyoxal agarose | |
| Andersson et al. | The effects of organic solvents and temperature on the desorption of yeast 3-phosphoglycerate kinase from immunoadsorbent | |
| US4325866A (en) | Protein, PP11, a process for its preparation and its use | |
| US4065445A (en) | Pregnancy-specific β1 -glycoprotein and process for isolating it | |
| US4264449A (en) | Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith | |
| US4232004A (en) | Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith | |
| US4592863A (en) | Protein PP20, a process for obtaining it, and its use | |
| Aalberse et al. | The purification of human polyclonal IgE by immunosorption | |
| JPS6034916A (ja) | 第１ｘ因子および他のビタミンｋ依存性タンパク質の高純度精製 | |
| US4374061A (en) | Means and methods for purifying Clq, Clr and Cls | |
| US4594328A (en) | Tissue protein PP21, a process for obtaining it and its use | |
| US4018885A (en) | Steroid-binding globulin and process for preparing it and antibodies thereto | |
| US4879216A (en) | Specific antibody against heart muscle light chains, a process for the preparation thereof and a reagent containing it | |
| US4599318A (en) | Tissue protein PP19, a process for obtaining it, and its use | |
| EP0310719B1 (en) | Method for purification of antibodies | |
| GB1599435A (en) | Glycoprotein and process for its production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |